Bicycle Therapeutics (BCYC) Change in Receivables (2018 - 2025)

Bicycle Therapeutics' Change in Receivables history runs 7 years deep, the most recent figure standing at $133000.0 for Q1 2025.

• Quarterly Change in Receivables changed N/A year-over-year to $133000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $170000.0 (changed N/A YoY) and the FY2023 annual result came in at -$2.5 million, down 251.25% from the prior year.
• Change in Receivables was $133000.0 for Q1 2025 at Bicycle Therapeutics, down from $49.9 million in the prior quarter.
• Across five years, Change in Receivables topped out at $49.9 million in Q3 2023 and bottomed at -$49.8 million in Q2 2023.
• A 4-year average of -$477363.6 and a median of -$991000.0 in 2022 frame the typical range for Change in Receivables.
• Peak annual rise in Change in Receivables reached 614.5% in 2023, while the deepest fall reached 582.14% in 2023.
• Bicycle Therapeutics' Change in Receivables stood at $1.0 million in 2021, then jumped by 98.7% to $2.0 million in 2022, then soared by 2407.59% to $49.9 million in 2023, then plunged by 99.73% to $133000.0 in 2025.
• Business Quant data shows BCYC's Change in Receivables at $133000.0 in Q1 2025, $49.9 million in Q3 2023, and -$49.8 million in Q2 2023.